Aplastic anaemia

Published on 03/04/2015 by admin

Filed under Hematology, Oncology and Palliative Medicine

Last modified 03/04/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1084 times

26

Aplastic anaemia

The term aplastic anaemia is a misnomer in that the disorder so described is characterised by a pancytopenia arising from failure of production of all the normal cells of peripheral blood. The underlying cause is a reduction in the number of pluripotential stem cells. This deficit may be exacerbated by an abnormality in the marrow microenvironment or an autoimmune reaction against the abnormal haematopoietic tissue.

Aplastic anaemia is rare (approximately 2–5 cases/million/year worldwide) and affects all ages. It must be emphasised that it is not a subtype of leukaemia. However, the disease’s presenting clinical characteristics, the management problems of marrow failure (including fulminating septicaemia and haemorrhage) and the possible evolution to a clonal marrow disorder dictate its inclusion in this section.

Classification and aetiology

Aplastic anaemia (AA) may be part of a congenital syndrome, be secondary to well-defined insults to the bone marrow, or arise apparently spontaneously with no identifiable cause. A simple classification is shown in Table 26.1. The most common congenital disorder is Fanconi’s anaemia. Affected children suffer from defective DNA repair and the aplasia often coexists with skeletal deformities, skin pigmentation (Fig 26.1) and renal abnormalities. To date, fifteen genes (termed FANC) have been identified. Dyskeratosis congenita, another form of constitutional aplasia, is distinguished by a later onset, nail dystrophy, leukoplakia of mucosal surfaces and a high incidence of epithelial tumours. There is defective telomere maintenance and patients usually have very short telomeres. This is also observed in 10–15% of patients with acquired AA.

Table 26.1

Classification of aplastic anaemia

1. Idiopathic AA  
2. Congenital AA Fanconi’s anaemia
  Dyskeratosis congenita
3. Secondary AA Drugs – idiosyncratic or dose-related
  Chemicals
  Ionising radiation
  Infection

Infections known to predispose to AA include viral hepatitis and parvovirus infection. Exposure to chemicals, drugs and radiation can damage stem cells. Drugs may depress haematopoiesis idiosyncratically or predictably (Table 26.2). In roughly two-thirds of patients, no cause is apparent and AA is termed ‘idiopathic’. Improved haematopoiesis following immunosuppression (see below) suggests that in at least some cases the abnormal stem cell compartment is further compromised by poorly defined immune phenomena.

Table 26.2

Drugs associated with aplastic anaemia1

Predictable Cytotoxic agents
Idiosyncratic Chloramphenicol
  Sulfonamides
  Phenylbutazone
  Indometacin
  Gold salts
  Penicillamine
  Carbamazepine
  Phenytoin
  Carbimazole

1This is a selective list of more commonly implicated agents.

Clinical features

Buy Membership for Hematology, Oncology and Palliative Medicine Category to continue reading. Learn more here